MedTrace Logo

GalaFlex Mesh in Facelift

NCT02053831 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2023-05-16

No results posted yet for this study

Summary

In this post market study a resorbable mesh (GalaFLEX) will be used to reinforce the lifted and imbricated SMAS along the suture lines and spread the load of the SMAS along a greater surface area. GalaFLEX mesh is comprised of resorbable 4-hydroxybutyrate fibers.

Conditions

  • Superficial Musculoaponeurotic System (SMAS) Procedure

Sponsors & Collaborators

  • Tepha, Inc.

    collaborator INDUSTRY

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Arikha Moses, Ph.D · Chief Scientific Officer, Founder

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-03-31
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02053831 on ClinicalTrials.gov